STEPHEN HAHN to Dihematoporphyrin Ether
This is a "connection" page, showing publications STEPHEN HAHN has written about Dihematoporphyrin Ether.
Connection Strength
0.809
-
Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy. Clin Cancer Res. 2006 Sep 15; 12(18):5464-70.
Score: 0.293
-
A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res. 2006 Apr 15; 12(8):2517-25.
Score: 0.285
-
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res. 2004 Jul 15; 10(14):4630-8.
Score: 0.063
-
Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. J Biomed Opt. 2003 Apr; 8(2):248-52.
Score: 0.058
-
Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy. Clin Cancer Res. 2001 Dec; 7(12):3904-11.
Score: 0.053
-
Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Res. 1999 Sep 01; 59(17):4334-42.
Score: 0.045
-
Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann Surg Oncol. 2001 Apr; 8(3):254-9.
Score: 0.013